Drug Conjugate Program:


We have levereaged the unique structure of the Surrobody to create a directed path for drug conjugation. Our proof of concept work has deomonstrated the increased potency of drug conjugated Surrobodies over unconjugated Surrobodies in vitro as well as favorable production, conjugation and stability characteristics.




For more information, including information on bispecific drug conjugates please contact us.

© 2010, Sea Lane Biotechnologies, LLC.  All Rights Reserved.